The ZIVOLABS journal

Things worth knowing — before, during, after.

Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.

Browse the full article library

Results

Showing 110 of 10
Indian context· 4 min

Why obesity rates are rising fastest in India

The numbers, the drivers, and why prevention has limits — making medical treatment increasingly relevant.

28 Mar 2026
Indian context· 3 min

Why some pharmacies refuse to dispense GLP-1 without a recent Rx

Pharmacists are gatekeepers, not vending machines. There's a legal reason behind the friction.

27 Mar 2026
Indian context· 2 min

GST on prescription medication — what you actually pay

12% on the drug. 18% on some services. Here's the full breakdown so you know what's on your invoice.

26 Mar 2026
Indian context· 4 min

Will my employer health insurance cover GLP-1?

The honest answer depends on the diagnosis on your claim. Here's the playbook.

24 Mar 2026
Indian context· 3 min

CDSCO oversight: what it means for medication safety

Every legitimate GLP-1 pen in India passes through CDSCO. Here's what that actually means for what you receive.

23 Mar 2026
Indian context· 3 min

Cost of GLP-1 across Indian cities

Same medication, different price by city. Why and what it means for budgeting.

22 Mar 2026
Indian context· 4 min

Why Ozempic shortages keep happening

Every few months you hear that Ozempic is out of stock. Here's why the supply is so tight — and what alternatives are available.

21 Mar 2026
Indian context· 3 min

DCGI approval status of GLP-1 medications in India

What the Drugs Controller General of India has actually approved — and for which conditions.

20 Mar 2026
Indian context· 4 min

NMC Act 2020 and what it means for your telemedicine consult

The legal framework that makes your remote doctor consult valid. The short version, and what it requires from us.

19 Mar 2026
Indian context· 3 min

Brand names you'll see in India — the cheat sheet

Ozempic. Rybelsus. Wegovy. Mounjaro. Saxenda. Trulicity. What each is and which conditions they're approved for.

14 Mar 2026
ZIVOLABS prescription GLP medication — vial (weekly injection) and bottle (daily oral dissolving tablets)
Now accepting patients

Not a diet. Not a gym plan.
Medical science. Finally in India.

  • Available as weekly injection or daily tablets
  • Around 15% average weight loss in major GLP‑1 trials — results vary*
  • Unlimited 24/7 support from our care team
  • Start with a ₹499 doctor consultation — refunded if you’re not eligible
  • Medication & ongoing care quoted separately — price shown before you pay
Am I qualified?
Takes 5 minutes. No commitment required.
NMC-registered doctors DCGI-approved medication Licensed pharmacy delivery
*Average weight loss seen in published GLP-1 RA trials over 68 weeks. Individual results vary. Read the medical disclaimer.